blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3037101

EP3037101 - Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.01.2020
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  01.02.2019
FormerGrant of patent is intended
Status updated on  14.10.2018
FormerExamination is in progress
Status updated on  20.03.2017
FormerRequest for examination was made
Status updated on  23.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Ferring B.V.
Polaris Avenue 144
2132 JX Hoofddorp / NL
[2016/26]
Inventor(s)01 / Arce, Joan-Carles
Soevej 100
2791 Dragor / DK
 [2016/26]
Representative(s)V.O.
P.O. Box 87930
2508 DH Den Haag / NL
[2016/26]
Application number, filing date14199709.822.12.2014
[2016/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3037101
Date:29.06.2016
Language:EN
[2016/26]
Type: B1 Patent specification 
No.:EP3037101
Date:06.03.2019
Language:EN
[2019/10]
Search report(s)(Supplementary) European search report - dispatched on:EP13.08.2015
ClassificationIPC:A61K38/08, A61K31/404, A61B17/435, A61K31/57, A61K38/11, A61K38/12, A61K45/06, A61K9/00, A61K31/4045, A61K31/565, // A61P15/08
[2018/36]
CPC:
A61K31/57 (EP,CN,IL,KR,US); A61K31/404 (CN,IL,KR,US); A61B17/435 (CN,IL,KR,US);
A61K31/4045 (EP,KR,US); A61K31/565 (EP,KR,US); A61K38/095 (EP,CN,KR,US);
A61K38/12 (EP,CN,IL,KR,US); A61K45/06 (EP,KR,US); A61K9/0019 (EP,KR,US);
A61K9/0034 (KR,US); A61P15/06 (EP); A61P15/08 (EP);
A61P43/00 (EP); A61K2300/00 (KR) (-)
C-Set:
A61K31/4045, A61K2300/00 (EP,US);
A61K31/565, A61K2300/00 (US,EP);
A61K31/57, A61K2300/00 (US,EP)
Former IPC [2016/26]A61K38/08, // A61P15/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/04]
Former [2016/26]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Oxytocinrezeptorantagonistentherapie in der Lutealphase für Implantation und Schwangerschaft bei mit Technologien zur unterstützten Fortpflanzung behandelten Frauen[2016/26]
English:Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies[2016/26]
French:Thérapie par antagoniste du récepteur de l'oxytocine dans la phase lutéinique pour l'implantation et la grossesse chez les femmes subissant des technologies de reproduction assistée[2016/26]
Examination procedure22.12.2014Date on which the examining division has become responsible
19.12.2016Amendment by applicant (claims and/or description)
19.12.2016Examination requested  [2017/04]
21.03.2017Despatch of a communication from the examining division (Time limit: M06)
19.09.2017Reply to a communication from the examining division
15.10.2018Communication of intention to grant the patent
23.01.2019Fee for grant paid
23.01.2019Fee for publishing/printing paid
23.01.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19153560.8  / EP3501533
Opposition(s)09.12.2019No opposition filed within time limit [2020/07]
Fees paidRenewal fee
13.12.2016Renewal fee patent year 03
12.12.2017Renewal fee patent year 04
31.12.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.12.2014
AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
MK06.03.2019
MT06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
[2022/31]
Former [2021/34]HU22.12.2014
AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
MT06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2021/32]HU22.12.2014
AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2021/26]AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/39]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/13]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/09]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/04]AL06.03.2019
AT06.03.2019
CZ06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/03]AL06.03.2019
AT06.03.2019
CZ06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/51]AL06.03.2019
CZ06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/49]AL06.03.2019
CZ06.03.2019
EE06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/48]FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RS06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/39]FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
RS06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
Former [2019/38]FI06.03.2019
LT06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
Former [2019/37]FI06.03.2019
LT06.03.2019
SE06.03.2019
NO06.06.2019
GR07.06.2019
Former [2019/34]FI06.03.2019
LT06.03.2019
SE06.03.2019
NO06.06.2019
Former [2019/33]FI06.03.2019
LT06.03.2019
NO06.06.2019
Documents cited:Search[A]WO9823636  (FERRING BV [NL], et al) [A] 1-15* the whole document *;
 [XI]WO2006121362  (FERRING INT CT SA [CH], et al) [X] 1 * page 11, paragraph last - page 12, paragraph first * [I] 2-4;
 [XI]  - MORALOGLU O ET AL, "Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF", REPRODUCTIVE BIOMEDICINE ONLINE, REPRODUCTIVE HEALTHCARE LTD, GB, vol. 21, no. 3, ISSN 1472-6483, (20100901), pages 338 - 343, (20100825), XP027238024 [X] 1 * the whole document * [I] 2-4
 [A]  - VRACHNIS NIKOLAOS ET AL, "The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.", INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2011, (2011), vol. 2011, ISSN 1687-8345, page 350546, XP002742088 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1155/2011/350546
by applicantUS6143722
 US6605468
 WO2004020414
 WO2005028452
 WO2010010201
 WO2010010213
 US2012252119
 WO2013078312
 US2014017717
 US2014134632
    - PRADOS ET AL., HUMAN REPRODUCTION, (2012), vol. 27, pages 50 - 71
    - MERKUS, F. W. H. M. ET AL., J. CONTROLLED RELEASE, (1993), vol. 24, pages 201 - 208
    - AYOUBI J-M; EPINEY M; BRIOSCHI PA; FANCHIN R; CHARDONNENS D; DE ZIEGLER D, "Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in in vitro fertilization cycles", FERTIL STERIL, (2003), vol. 79, pages 1101 - 1105
    - BERGH PA; NAVOT D, "The impact of embryonic development and endometrial maturity on the timing of implantation", FERTIL STERIL, (1992), vol. 58, pages 537 - 542
    - BERNABEU R; ROCA M; TORRES A; TEN J, "Indomethacin effect on implantation rates in oocyte recipients", HUM REPROD, (2006), vol. 21, pages 364 - 369
    - BLOCKEEL C; PIERSON R; POPOVIC-TODOROVIC B; VISNOVA H; GARCIA-VELASCO JA; MRAZEK M; CHOU P-Y; WU M-H; PAN H-A; HUNG K-H, "Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study", TAIWAN J OBSTET GYNECOL, (2011), vol. 40, pages 136 - 140
    - FANCHIN R; RIGHINI C; OLIVENNES F; TAYLOR S; DE ZIEGLER D; FRYDMAN R, "Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization", HUM REPROD, (1998), vol. 13, doi:doi:10.1093/humrep/13.7.1968, pages 1968 - 1974, XP055090276

DOI:   http://dx.doi.org/10.1093/humrep/13.7.1968
    - FANCHIN R; RIGHINI C; DE ZIEGLER D; OLIVENNES F; LEDEE N; FRYDMAN R, "Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer", FERTIL STERIL, (2001), vol. 75, doi:doi:10.1016/S0015-0282(01)01787-3, pages 1136 - 1140, XP009174620

DOI:   http://dx.doi.org/10.1016/S0015-0282(01)01787-3
    - FUCHS A-R; BEHRENS O; MASCHEK H; KUPSCH E; EINSPANIER A, "Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy", HUM REPROD UPDATE, (1998), vol. 4, pages 594 - 604
    - KILLICK SR, "Ultrasound and the receptivity of the myometrium", RBM ONLINE, (2007), vol. 15, pages 63 - 67
    - KIM CH; LEE JW; JEON IK; PARK E; LEE YJ; KIM SH; CHAE H; KANG BM; LEE HA, "Administration of oxytocin antagonist improves the implantation rates in patients with repeated failure of IVF/ICSI treatment", HUM REPROD, (2008), vol. 23, no. 1, page I124
    - KOOT YEM; MACKLON NS, "Embryo implantation: biology, evaluation, and enhancement", CURR OPIN OBSTET GYNECOL, (2013), vol. 25, pages 274 - 279
    - LAN VT; KHANG VN; NHU GH; THUONG HM, "Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure", RBM ONLINE, (2012), vol. 25, pages 254 - 260
    - LESNY P; KILLICK SR; TETLOW RL; ROBINSON J; MAGUINESS SD, "Embryo transfer - can we learn anything new from the observation of junctional zone contractions?", HUM REPROD, (1998), vol. 13, pages 1540 - 1546
    - LIANG YL; KUO TC; HUNG KH; CHEN TH; WU MH, "Oxytocin antagonist for repeated implantation failure and delay of delivery", TAIWAN J OBSTET GYNECOL, (2009), vol. 48, pages 314 - 316
    - MAKRIGIANNAKIS A; MINAS V, "Mechanisms of implantation", RBM ONLINE, (2006), vol. 14, pages 102 - 109
    - MOON HS; PARK SH; LEE JO; KIM KS; JOO BS, "Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer", FERTIL STERIL, (2004), vol. 82, doi:doi:10.1016/j.fertnstert.2004.02.140, pages 816 - 820, XP004598841

DOI:   http://dx.doi.org/10.1016/j.fertnstert.2004.02.140
    - MORALOGLU O; TONGUC E; TURGUT V; ZEYREK T; BATIOGLU S, "Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF", RBM ONLINE, (2010), vol. 21, pages 338 - 343, XP027238024
    - NG EH; LI RH; CHEN L; LAN VT; TUONG HM; QUAN S, "A randomized double blind comparison of atosiban in patients undergoing IVF treatment", HUM REPROD, (2014), vol. 29, doi:doi:10.1093/humrep/deu263, pages 2687 - 2694, XP055411770

DOI:   http://dx.doi.org/10.1093/humrep/deu263
    - PAPANIKOLAOU EG; KOLIBIANAKIS EM; TOURNAYE H; VENETIS CA; FATEMI H; TARLATZIS B; DEVROEY P, "Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF", A SYSTEMATIC REVIEW AND META-ANALYSIS. HUM REPROD, (2008), vol. 23, pages 91 - 99
    - PIERZYNSKI P; REINHEIMER TM; KUCZYNSKI W, "Oxytocin antagonists may improve infertility treatment", FERTIL STERIL, (2007), vol. 88, pages E19 - E22
    - RICHTER ON; BARTZ C; DOWAJI J; KUPKA M; REINSBERG J; ULRICH U; RATH W, "Contractile reactivity of human myometrium in isolated non-pregnant uteri", HUM REPROD, (2006), vol. 21, pages 36 - 45
    - SCHOOLCRAFT WB; SURREY ES; GARDNER DK, "Embryo transfer: techniques and variables affecting success", FERTIL STERIL, (2001), vol. 76, pages 863 - 870
    - SIMON C; MARTIN JC; PELLICER A, "Paracrine regulators of implantation", CLIN OBSTET GYNAECOL, (2000), vol. 14, pages 815 - 826
    - SHUKOVSKI L; HEALY DL; FINDLAY JK, "Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent", J CLIN ENDOCRINOL METAB, (1989), vol. 68, pages 455 - 460
    - STROWITZKI T; GERMEYER A; POPOVICI R; WOLFF M, "The human endometrium as a fertility-determining factor", HUM REPROD UPDATE, (2006), vol. 12, pages 617 - 630
    - ZHU L; CHE HS; XIAO L; LI YP, "Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles", HUM REPROD, (2014), vol. 29, doi:doi:10.1093/humrep/deu058, pages 1238 - 1243, XP055411083

DOI:   http://dx.doi.org/10.1093/humrep/deu058
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.